Health Economic Assessments in France (CEESP-HAS): From Practice to Insights

Life Sciences, Pharmaceutical Regulation, Pharmaceutical, Medical Device, Commercialization & HEOR, Medical Device Safety and Regulation,
  • Tuesday, November 24, 2020 | 10am EST (NA) / 3pm GMT (UK) / 4pm CET (EU-Central)
  • 60 min

In France, manufacturers of innovative drugs are required to submit cost-effectiveness analysis and, in some cases, budget impact analysis, which the French Economic and Public Health Committee (CEESP) at the French Health Authority (HAS), use to deliver an economic opinion to the country’s pricing committee. Since 2013, these opinions have fundamentally evolved, and more recently, the methodological framework for the cost-effectiveness analysis at the HAS was updated, with major changes.

Having a good understanding of these changes and their impact is critical to prepare a high quality of submission file and can increase the likelihood of a timely, and successful positive opinion from the CEESP.

Join us to learn about the process leading to an economic opinion, the impact of the July 2020 methodological guidance, and how to choose the best methodology and effectively present it. We will focus on cost-effectiveness analysis for medicinal products and provide insights on:

  • The key points of the choice of comparators
  • The new guidelines for economic evaluation at the HAS, published in July 2020
  • Recent CEESP economic opinions, based on a review between 2014 and 2020

Speakers

http://Delaitre%20Bonnin%20Caroline,%20ICON%20plc

Caroline Delaitre-Bonnin, Senior Principal, HTA and Value Communications Lead, Health Economics and Outcome Research, ICON

Caroline joined ICON in 2009 and has over 15 years of healthcare experience spanning industry and consulting. Her primary focus is on market access and pricing projects with extensive experience in oncology, haematology, gastroenterology and orphan drugs. She has been involved in projects on health policy, health technology assessment, and public health programs assessment, including disease management. Her activities include due diligences for mergers and acquisitions and licensing.

Message Presenter
http://Fabienne%20Midy,%20PhD,%20ICON%20plc

Fabienne Midy, PhD, Lead Consultant, Health Economics Outcomes and Research, ICON plc

Fabienne joined ICON in September 2020 as a lead consultant. Fabienne is a health economist, with more than 17 years of professional experience in health economic evaluation and health technology assessment. She has obtained a PhD, the subject of which was the evaluation of quality of life. After five years working in the health economics research field, she worked nearly 17 years at the French Health Authority (HAS). The last seven years of her time at the HAS, she actively participated in the Economic Advice mission analysing industrial files submitted to the CEESP. She was also in charge of the scientific coordination of the methodological guidelines on economic evaluation for HAS (2011 and 2020 version).

Message Presenter

Who Should Attend?

This program is intended for professionals from pharmaceutical, biotech, and medical device companies involved in the development and submission of economic evaluation dossiers in France, including:

  • Health technology assessment (HTA)
  • Health economics & outcomes research (HEOR)
  • Marketing
  • Market access, pricing & reimbursement

What You Will Learn

The featured speakers will focus on cost-effectiveness analysis for medicinal products and provide insights on:

  • The key points of the choice of comparators
  • The new guidelines for economic evaluation at the HAS, published in July 2020
  • Recent CEESP economic opinions, based on a review between 2014 and 2020

Xtalks Partner

ICON

ICON plc is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specializes in the strategic development, management and analysis of programs that support clinical development. With headquarters in Dublin, Ireland, ICON currently operates from 97 locations in 38 countries and has approximately 13,380 employees. Further information is available at ICONplc.com.

Media Partner

The original site for employees in the pharma, medical, diagnostic and related industries. Our hand-curated daily news feed and active message forums will keep you informed. 

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account